ABCA1 and inflammatory breast carcinoma: Interestingly, ABCA1, the primary cholesterol transporter in HDL trafficking previously described by our group as important in mediating the beneficial effects of HDL in IBC patients and pre-clinical studies is upregulated in IBC [32].